Mirioglu, S. Et Al. 2024. Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use. Clinical Kidney Journal , vol.17, no.7 .

Mirioglu, S., Hocaoglu, R. H., VELİOĞLU, A., ÖZLÜK, M. Y., DİRİM, A. B., ORUÇ, A., ... OTO, Ö. A.(2024). Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use. Clinical Kidney Journal , vol.17, no.7.

Mirioglu, Safak Et Al. "Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use," Clinical Kidney Journal , vol.17, no.7, 2024

Mirioglu, Safak Et Al. "Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use." Clinical Kidney Journal , vol.17, no.7, 2024

Mirioglu, S. Et Al. (2024) . "Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use." Clinical Kidney Journal , vol.17, no.7.

@article{article, author={Safak Mirioglu Et Al. }, title={Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use}, journal={Clinical Kidney Journal}, year=2024}